{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:24:56Z","timestamp":1776281096900,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>Uterine leiomyosarcoma (U-LMS) is the most frequent malignant gynecologic mesenchymal tumor, often develops distant metastases and has a dismal prognosis. In this study we aim to characterize the body sites and time to metastasis in women with U-LMS. We evaluated 130 U-LMSs with distant metastases including a series of patients diagnosed at 2 tertiary centers, as well as cases published in the literature, found using a PubMed query. Data collected included clinic-pathologic features, time to first metastasis, and survival. Survival analysis was performed using univariable and multivariable Cox regression model. The most frequent metastatic sites were: lung (67.7%), cranial\/intracranial (16.2%), skin\/soft tissues (15.3%), and bone (13.8%). Other sites included thyroid, salivary gland, heart, liver, pancreas, adrenal gland, bowel, and breast. Metastases were histologically identical to primary tumors. Median time to first metastasis was highly variable (median: 24 mo; range, 1 mo to 26 y). Lung and peritoneum were the earlier metastatic sites; 21.4% of patients with U-LMS limited to the pelvis develop metastasis &gt;5 yr after diagnosis. Lung metastases significantly associated with other distant metastases. Regarding treatment, only resection of metastases significantly influenced postmetastasis survival in multivariable analysis (hazard ratio: 0.49, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.015). In conclusion, U-LMS display highly variable sites of distant metastases. Metastases in unusual locations are sometimes the first to be detected, and not uncommonly, single and prone to surgical resection. There is also a wide range of time intervals to first metastasis, highlighting the need of long-term follow-up, high level of suspicion, and appropriate diagnostic confirmation.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000284","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T12:16:25Z","timestamp":1458908185000},"page":"31-41","source":"Crossref","is-referenced-by-count":35,"title":["Distant Metastases in Uterine Leiomyosarcomas: The Wide Variety of Body Sites and Time Intervals to Metastatic Relapse"],"prefix":"10.1097","volume":"36","author":[{"given":"Carla","family":"Bartosch","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Ana S.","family":"Pires-Lu\u00eds","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Galaghar","sequence":"additional","affiliation":[]},{"given":"Marcos","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Lopes","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","article-title":"Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999","volume":"93","author":"Brooks","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","article-title":"Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma","volume":"106","author":"Giuntoli","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/gyno.2002.6840","article-title":"Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma","volume":"87","author":"Leitao","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2012.02.014","article-title":"Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis","volume":"125","author":"Leitao","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0090-8258(84)90176-8","article-title":"Autopsy findings in patients with uterine sarcoma","volume":"19","author":"Fleming","year":"1984","journal-title":"Gynecol Oncol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/1097-0142(19890301)63:5<935::AID-CNCR2820630525>3.0.CO;2-9","article-title":"Patterns of metastasis in uterine sarcoma. An autopsy study","volume":"63","author":"Rose","year":"1989","journal-title":"Cancer"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3802\/jgo.2014.25.4.306","article-title":"Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients","volume":"25","author":"Tirumani","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/modpathol.3880055","article-title":"Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus","volume":"13","author":"Kempson","year":"2000","journal-title":"Mod Pathol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00000478-198210000-00001","article-title":"Myxoid leiomyosarcoma of the uterus. A report of six cases","volume":"6","author":"King","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/gyno.1996.0185","article-title":"Uterine leiomyosarcoma: analysis of treatment failures and survival","volume":"62","author":"Gadducci","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004347-199507000-00008","article-title":"Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis","volume":"14","author":"Jones","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ygyno.2003.10.044","article-title":"The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital","volume":"92","author":"Dinh","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.1999.5436","article-title":"Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases","volume":"74","author":"Mayerhofer","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/IGC.0000000000000221","article-title":"Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma","volume":"24","author":"Rauh-Hain","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1097\/PAS.0b013e31822b44d2","article-title":"\u201cLow-grade leiomyosarcoma\u201d and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas","volume":"35","author":"Veras","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R22-20230824","first-page":"1001","article-title":"Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior","volume":"52","author":"Giuntoli","year":"2007","journal-title":"J Reprod Med"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/modpathol.2009.122","article-title":"A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors","volume":"22","author":"Lee","year":"2009","journal-title":"Mod Pathol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1002\/cncr.24486","article-title":"Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups","volume":"115","author":"Carvalho","year":"2009","journal-title":"Cancer"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAS.0b013e318208e361","article-title":"Inguinal smooth muscle tumors in women-a dichotomous group consisting of Mullerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases","volume":"35","author":"Patil","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0090-8258(03)00478-5","article-title":"Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus","volume":"91","author":"Leitao","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"Kapp","year":"2008","journal-title":"Cancer"},{"key":"R30-20230824","first-page":"485","article-title":"Analysis of treatment failures in patients with early-stage uterine leiomyosarcoma","volume":"15","author":"Gadducci","year":"1995","journal-title":"Anticancer Res"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/PAS.0b013e31820ca624","article-title":"Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases","volume":"35","author":"Wang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-0412.2003.820114.x","article-title":"Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases","volume":"82","author":"Hsieh","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1425::AID-CNCR21>3.0.CO;2-3","article-title":"Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma","volume":"88","author":"Pautier","year":"2000","journal-title":"Cancer"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2005.08.010","article-title":"Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma","volume":"100","author":"Wu","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/IGC.0b013e3181acae50","article-title":"Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience","volume":"19","author":"Mahdavi","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)","volume":"44","author":"Reed","year":"2008","journal-title":"Eur J Cancer"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.cco.0000127721.55676.f6","article-title":"Uterine leiomyosarcoma: present management","volume":"16","author":"Giuntoli","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/IGC.0000000000000372","article-title":"Trends in the treatment of uterine leiomyosarcoma in the Medicare population","volume":"25","author":"Foley","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1748-717X-8-128","article-title":"Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma","volume":"8","author":"Wong","year":"2013","journal-title":"Radiat Oncol"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bpobgyn.2011.06.004","article-title":"Role of radiotherapy treatment of uterine sarcoma","volume":"25","author":"Sampath","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bpobgyn.2011.06.003","article-title":"Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas","volume":"25","author":"Hensley","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.athoracsur.2011.05.052","article-title":"Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival","volume":"92","author":"Burt","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R44-20230824","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/IGC.0b013e3181c9e289","article-title":"Metastatic uterine leiomyosarcomas: a single-institution experience","volume":"20","author":"Bernstein-Molho","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R45-20230824","first-page":"919323","article-title":"Prognostic factors and survival in patients treated surgically for recurrent metastatic uterine leiomyosarcoma","volume":"2014","author":"Hoang","year":"2014","journal-title":"Int J Surg Oncol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201701000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:22:55Z","timestamp":1692840175000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201701000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000284","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}